{"transactions":[{"id":2921057,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":144145,"kind":"person","name":"Rizvi Qasim","position":1,"cik":"0001794636","reported_name":"Rizvi Qasim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Unit","published_at":"2021-01-05T22:07:03.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":7337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSU."}],"balance_after":0,"derivative":{"underlying":"Class A Common Share","underlying_shares":7337},"source":{"system":"sec-edgar","filing":"0001179110-21-000197","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911021000197/edgar.xml","form_type":"4"}},{"id":2921056,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":144145,"kind":"person","name":"Rizvi Qasim","position":1,"cik":"0001794636","reported_name":"Rizvi Qasim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Share","published_at":"2021-01-05T22:07:03.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":2161,"price":17.67,"value":38184.87,"ownership":{"direct":true},"balance_after":5176,"source":{"system":"sec-edgar","filing":"0001179110-21-000197","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911021000197/edgar.xml","form_type":"4"}},{"id":2921055,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":144145,"kind":"person","name":"Rizvi Qasim","position":1,"cik":"0001794636","reported_name":"Rizvi Qasim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Share","published_at":"2021-01-05T22:07:03.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":7337,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":7337,"source":{"system":"sec-edgar","filing":"0001179110-21-000197","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911021000197/edgar.xml","form_type":"4"}},{"id":3032401,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":144145,"kind":"person","name":"Rizvi Qasim","position":1,"cik":"0001794636","reported_name":"Rizvi Qasim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Share Option","published_at":"2020-09-14T21:09:56.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is September 10, 2020."}],"balance_after":75000,"derivative":{"exercise_price":15.5,"expiration_date":"2030-09-09","underlying":"Class A Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-20-009720","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911020009720/edgar.xml","form_type":"4"}},{"id":3205629,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":144145,"kind":"person","name":"Rizvi Qasim","position":1,"cik":"0001794636","reported_name":"Rizvi Qasim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Share Option","published_at":"2020-03-17T21:22:38.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is March 13, 2020."}],"balance_after":75000,"derivative":{"exercise_price":15.52,"expiration_date":"2030-03-12","underlying":"Class A Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-20-003834","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911020003834/edgar.xml","form_type":"4"}},{"id":3341069,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":144145,"kind":"person","name":"Rizvi Qasim","position":1,"cik":"0001794636","reported_name":"Rizvi Qasim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Share Units","published_at":"2019-12-16T21:54:06.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":7337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Share Units will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Share Units will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date."}],"balance_after":7337,"derivative":{"underlying":"Class A Common Shares","underlying_shares":7337},"source":{"system":"sec-edgar","filing":"0001179110-19-012840","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911019012840/edgar.xml","form_type":"4"}},{"id":3348277,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":144145,"kind":"person","name":"Rizvi Qasim","position":1,"cik":"0001794636","reported_name":"Rizvi Qasim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Shares","published_at":"2019-12-09T22:58:39.000Z","date":"2019-12-06","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is December 9, 2019."}],"balance_after":30000,"derivative":{"exercise_price":10.61,"expiration_date":"2029-12-05","underlying":"Class A Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001179110-19-012551","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911019012551/edgar.xml","form_type":"4"}}]}